• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.64% Nasdaq Down0.55%

    Halozyme Therapeutics, Inc. (HALO)

    -NasdaqGS
    17.35 Down 0.33(1.87%) May 29, 4:00PM EDT
    |After Hours : 17.35 0.00 (0.00%) May 29, 4:24PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 18,666   30,377   14,606   18,385  
    Cost of Revenue6,494  6,147  5,141  5,924  
    Gross Profit 12,172   24,230   9,465   12,461  
    Operating Expenses
    Research Development16,684  19,728  19,904  18,649  
    Selling General and Administrative9,399  8,353  8,587  8,752  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (13,911) (3,851) (19,026) (14,940)
    Income from Continuing Operations
    Total Other Income/Expenses Net102  (45)122  118  
    Earnings Before Interest And Taxes(13,809)(3,896)(18,904)(14,822)
    Interest Expense1,299  1,378  1,376  1,451  
    Income Before Tax(15,108)(5,274)(20,280)(16,273)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(15,108)(5,274)(20,280)(16,273)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (15,108) (5,274) (20,280) (16,273)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (15,108) (5,274) (20,280) (16,273)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.